Medicalsystem(300439.SZ)

Company Encyclopedia
View More
name
Medicalsystem
300439.SZ
Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated chemistry analyzers; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; total laboratory automation system; mass spectrometry; and, blood lipid subfraction analyzer, and POCT.It also provides healthcare services.
1.522 T
300439.SZMarket value -Rank by Market Cap -/-

Financial Score

01/01/2026 Update
C
BiotechnologyIndustry
Industry Ranking52/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE3.22%C
    • Profit Margin6.40%B
    • Gross Margin38.09%B
  • Growth ScoreD
    • Revenue YoY-19.24%E
    • Net Profit YoY-62.48%D
    • Total Assets YoY2.58%C
    • Net Assets YoY2.36%C
  • Cash ScoreC
    • Cash Flow Margin1562.52%B
    • OCF YoY-19.24%E
  • Operating ScoreC
    • Turnover0.41C
  • Debt ScoreA
    • Gearing Ratio19.34%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Medicalsystem's subsidiary has obtained multiple medical device registration certificates

    Medicalsystem's holding subsidiary Jiangxi Meikang Shengde Biotechnology Co., Ltd. has obtained multiple medical device registration certificates issued by the Jiangxi Provincial Drug Administration. These registration certificates cover various in vitro diagnostic reagents, including tissue-type plasminogen activator - inhibitor 1 complex detection kit, thrombin - antithrombin complex detection kit, thrombomodulin detection kit, and plasmin-α2 plasmin inhibitor complex detection kit, all using chemiluminescent immunoassay

    Zhitong·
    SZ
    300439
    -0.20%
    Zhitong·
    SZ
    300439
    -0.20%

    Medicalsystem's subsidiary has obtained three medical device registration certificates

    Medicalsystem's holding subsidiary, Jiangxi Meikang Shengde Biotechnology Co., Ltd., has obtained three medical device registration certificates issued by the Jiangxi Provincial Drug Administration, including trace element testing kits, trace element quality control products, and uric acid/creatinine/urea testing kits. The acquisition of these registration certificates will enrich the company's product line, enhance core competitiveness and market expansion capabilities, and have a positive impact on future operations

    Zhitong·
    SZ
    300439
    -0.20%
    Zhitong·
    SZ
    300439
    -0.20%

    Medicalsystem: Net profit of 56.8337 million yuan in the first half of 2025, a year-on-year decrease of 68.15%

    Medicalsystem announced that in the first half of 2025, the operating revenue was 736 million yuan, a year-on-year decrease of 22.43%. The net profit was 56.8337 million yuan, a year-on-year decrease of 68.15%

    Zhitong·
    SZ
    300439
    -0.20%
    Zhitong·
    SZ
    300439
    -0.20%

    Medicalsystem obtained the medical device registration certificate

    Medicalsystem recently obtained the medical device registration certificate issued by the Zhejiang Provincial Drug Administration, covering the D-dimer test kit and the lipoprotein (a) test kit. The acquisition of this registration certificate will enrich the company's product line in the in vitro diagnostic field, enhance its core competitiveness and market expansion capabilities, and have a positive impact on future operations

    Zhitong·
    SZ
    300439
    -0.20%
    Zhitong·
    SZ
    300439
    -0.20%

    Medicalsystem establishes a new subsidiary, including biobased materials business

    According to the Qichacha APP, recently, Shenzhen Medicalsystem Biotechnology Co., Ltd. was established, with Zhang Yaotian as the legal representative and a registered capital of 5 million yuan. The business scope includes: sales of bio-based materials; production of Class II medical devices; production of Class III medical devices; operation of Class III medical devices, etc. Qichacha's equity penetration shows that the company is wholly owned by Medicalsystem

    Zhitong·
    SZ
    300439
    -0.20%
    Zhitong·
    SZ
    300439
    -0.20%
    © 2026 Longbridge｜Disclaimer